K Number
K030951
Device Name
TESCERAFLO A2, MODEL T-21012P; TESCERAFLO A2 OPAQUE, MODEL T-210120P
Manufacturer
Date Cleared
2003-06-06

(72 days)

Product Code
Regulation Number
872.3690
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
TESCERAFLO is a dual-cure (heat/light) composite designed to be used for direct or indirect restorations. Its physical properties are similar to the predicate device and uses are identical. Indications For Use: - l. Esthetic restorative material for Class III, IV, and V. - Conservative Class I and Class II not involving opposing occlusal contact for 2. direct or indirect use. - Direct Esthetic veneer restorative for masking stains and developmental 3. anomalies. - Pit and fissure sealant. 4. - న్. Core buildup material to replace missing tooth structure. - Direct cement/luting agent and dental liner. 6. - Indirect cement for use with reinforcement materials to fabricate crowns and 7. bridges. - 8. Composite/porcelain repair material.
Device Description
TESCERAFLO is a dual-cured (light/heat), moderately filled (60% by weight) low modulus flowable composite. It can be light cured by conventional means or processed in a dedicated curing device such as TESCERA ATL that employs heat and light in an oxygen-free environment. It is supplied in a syringe.
More Information

NTL-FLOW

Not Found

No
The document describes a dental composite material and its intended uses, with no mention of AI or ML technology.

No
The device is a restorative material for dental use, not a therapeutic device. Its purpose is to physically restore tooth structure or act as a sealant/cement, rather than to treat a disease or medical condition.

No

The device, TESCERAFLO, is described as a restorative and cementing material for dental applications, not as a tool for diagnosing medical conditions. Its uses are for treatment, repair, and restoration of teeth.

No

The device is a composite material supplied in a syringe, clearly indicating it is a physical substance and not software.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use of TESCERAFLO is for direct and indirect dental restorations, core buildup, cementation, and repair. These are all procedures performed on the patient's tooth structure.
  • IVD Definition: In Vitro Diagnostics are devices used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health.
  • Device Description: The description details a composite material used for filling and restoring teeth, not for analyzing biological samples.
  • Anatomical Site: The anatomical site is the tooth, which is the site of application, not the source of a diagnostic specimen.

The information provided clearly indicates that TESCERAFLO is a dental restorative material used directly in the mouth, not a device for testing biological samples outside the body.

N/A

Intended Use / Indications for Use

TESCERAFLO is a dual-cure (heat/light) composite designed to be used for direct or indirect restorations. Its physical properties are similar to the predicate device and uses are identical.

  • l. Esthetic restorative material for Class III, IV, and V.
  • Conservative Class I and Class II not involving opposing occlusal contact for 2. direct or indirect use.
  • Direct Esthetic veneer restorative for masking stains and developmental 3. anomalies.
  • Pit and fissure sealant. 4.
  • న్. Core buildup material to replace missing tooth structure.
  • Direct cement/luting agent and dental liner. 6.
  • Indirect cement for use with reinforcement materials to fabricate crowns and 7. bridges.
    1. Composite/porcelain repair material.

Product codes

EBF

Device Description

TESCERAFLO is a dual-cured (light/heat), moderately filled (60% by weight) low modulus flowable composite. It can be light cured by conventional means or processed in a dedicated curing device such as TESCERA ATL that employs heat and light in an oxygen-free environment. It is supplied in a syringe.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Side by side comparisons of TESCERAFLO to the predicate device NTL-FLOW clearly demonstrates that the applicant device is substantially equivalent to the legally marketed devices. TESCERAFLO was tested for biocompatibility and were found to be non-toxic. It is concluded that the information supplied in this submission has proven the safety and efficacy of TESCERAFLO.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

NTL-FLOW

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 872.3690 Tooth shade resin material.

(a)
Identification. Tooth shade resin material is a device composed of materials such as bisphenol-A glycidyl methacrylate (Bis-GMA) intended to restore carious lesions or structural defects in teeth.(b)
Classification. Class II.

0

K030951

Page 41 of 42

JUN - 6 2003

Section 5

Contact: Stephen D. Smith

510(k) SUMMARY

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 190 and 21 CFR par 807.92

Trade Name:TESCERAFLO
Common Name:Composite Restorative Material
Classification name:Material, Tooth Shade, Resin
Class II per 21 CFR 872.3690

Description of Applicant Device:

TESCERAFLO is a dual-cured (light/heat), moderately filled (60% by weight) low modulus flowable composite. It can be light cured by conventional means or processed in a dedicated curing device such as TESCERA ATL that employs heat and light in an oxygen-free environment. It is supplied in a syringe.

Intended uses of Applicant Device:

TESCERAFLO is a dual-cure (heat/light) composite designed to be used for direct or indirect restorations. Its physical properties are similar to the predicate device and uses are identical.

Predicate Devices: NTL-FLOW

NTL-FLOWTESCERAFLO
Intended useFlowable compositeFlowable composite
Chemical compositeDual-cured (light/heat) barium
glass and silica filled (60%),
dimethacrylate compositeDual-cured (light/heat) barium
glass and silica filled (60%),
dimethacrylate composite
Mechanical/Physical
PropertiesRelatively low viscosity,
syringable compositeRelatively low viscosity,
syringable composite

Significant Performance Characteristics:

Side by side comparisons of TESCERAFLO to the predicate device NTL-FLOW clearly demonstrates that the applicant device is substantially equivalent to the legally marketed devices. TESCERAFLO was tested for biocompatibility and were found to be non-toxic. It is concluded that the information supplied in this submission has proven the safety and efficacy of TESCERAFLO.

Stephen D. Smith Manager Regulatory Affairs Telephone: 847 534-6146 Fax: 847-534-6396

1

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image is a black and white circular logo for the U.S. Department of Health & Human Services. The logo features the department's name encircling an abstract symbol. The symbol is a stylized representation of a human figure, with three curved lines forming the body and head.

Public Health Service

JUN - 6 2003

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Kathy Joung, Ph.D. Director of Quality Systems Bisco, Incorporated 1100 West Irving Park Road Schaumburg, Illinois 60193

Re: K030951

Trade/Device Name: TESCERAFLO™ Regulation Number: 21 CFR 872.3690 Regulation Name: Tooth Shade Resin Material Regulatory Class: II Product Code: EBF Dated: March 24, 2003 Received: March 26, 2003

Dear Dr. Joung:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

2

Page 2 – Kathy Joung, Ph.D.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If vou desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on vour responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Susan Russe

Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

510(k) Submission for TESCERAFLO BISCO INC., I 100 West Irving Park Road Schaumburg, IL 60193

CONFIDENTIAL

510(k) Number (if known): K030951

Device Name: TESCERAFLO

Indications For Use:

  • l. Esthetic restorative material for Class III, IV, and V.
  • Conservative Class I and Class II not involving opposing occlusal contact for 2. direct or indirect use.
  • Direct Esthetic veneer restorative for masking stains and developmental 3. anomalies.
  • Pit and fissure sealant. 4.
  • న్. Core buildup material to replace missing tooth structure.
  • Direct cement/luting agent and dental liner. 6.
  • Indirect cement for use with reinforcement materials to fabricate crowns and 7. bridges.
    1. Composite/porcelain repair material.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Kein Marley for MSR

(Optional Format 3-10-98)

(Division Sign-C Division of Anesthesiology, General Hospital, Int-raion Control, Dental Device

510(k) Number: K030951

Page 10 of 40